kenacort
Kenacort (Triamcinolone Diacetate) is a medication used to treat Adrenal Insufficiency, Hemolytic Anemia, Berylliosis, Bronchial Spasm.
Triamcinolone Diacetate · by Delcor Asset Corp
Key facts
- Active ingredient
- Triamcinolone Diacetate
- Form
- Tablet
- Strength
- Triamcinolone Diacetate EQ 4MG BASE/5ML
- Type
- Prescription (Rx)
- Brand or generic
- Brand-name
- May treat
- adrenal insufficiency, hemolytic anemia, berylliosis
- Manufacturer
- Delcor Asset Corp
- FDA application
- NDA012515
- Availability
- Discontinued (per FDA)
May treat (source: NIH RxClass)
Dosage forms
Tablet
The forms currently marketed in the U.S., per the FDA National Drug Code Directory.
Ways to save
Ask for the generic
Same active ingredient, far cheaper. Is there a generic? →
Request a 90-day supply
Bulk fills usually lower the per-dose price vs monthly refills.
Use copay cards
Manufacturer copay cards & patient-assistance programs — especially for brand drugs.
Compare alternatives
A same-class option may cost less. See alternatives →
Frequently asked questions
- What does Kenacort treat?
- Kenacort (Triamcinolone Diacetate) may be used to treat adrenal insufficiency, hemolytic anemia, berylliosis, bronchial spasm, ulcerative colitis, dermatitis herpetiformis, based on NIH RxClass drug-classification data (conditions a drug may treat — not a verbatim copy of the FDA-approved label). This is general reference, not medical advice.
- Is there a coupon or discount for Kenacort?
- pharmaranks is an independent ratings site, not a pharmacy — we don't issue coupons or sell Kenacort. To pay less, ask your prescriber or pharmacist whether a generic equivalent exists, check the manufacturer's copay/savings card and patient-assistance program, and compare a pharmacy discount card against your insurance copay. Prices vary by pharmacy, insurance, and location, so always confirm at the counter. This is general reference, not medical or financial advice.
- Who makes Kenacort?
- Kenacort is marketed by Delcor Asset Corp. You can see Delcor Asset Corp's full profile, rating, and other products on pharmaranks.
- Is Kenacort a brand-name or generic drug?
- Kenacort is a brand-name product with the active ingredient Triamcinolone Diacetate.
- Is Kenacort available over the counter?
- No. Kenacort is a prescription (Rx) medication in the US — you need a prescription from a licensed clinician (in person or via telehealth); it isn't sold over the counter. For some conditions there are OTC alternatives — ask your pharmacist.
- What forms does Kenacort come in?
- Kenacort is currently marketed as tablet, per the FDA's National Drug Code Directory.
- Is Kenacort FDA-registered?
- Kenacort is on record with the U.S. FDA under application number NDA012515. You can verify this on its official FDA label.
Information is sourced from public FDA regulatory data. Provided for general reference only — not medical advice. Always consult a licensed professional and the current prescribing information.
What people report to the FDA about TRIAMCINOLONE DIACETATE
The FDA Adverse Event Reporting System (FAERS) collects reports from patients and clinicians. It holds 109 reports naming TRIAMCINOLONE DIACETATE — the active ingredient in Kenacort, and the FDA flagged 61% of those reports as serious. The effects reported most often — leaving out reports about overdose, misuse or the condition being treated, which dominate the raw list for common medicines:
- nausea25 reports
- nephrolithiasis21 reports
- sedation21 reports
- hyperhidrosis20 reports
- nightmare20 reports
- pruritus7 reports
- cough6 reports
- dermatitis atopic6 reports
Read these as a signal, not a rate. A report does not mean TRIAMCINOLONE DIACETATE caused the effect — anyone can file one, and many describe people taking several medicines for several conditions. Crucially there is no denominator: FAERS does not record how many people took the drug, so these counts cannot be turned into “X% of patients” — a bigger number often just means a more widely used or more talked-about drug. Duplicates exist, and publicity drives reporting. For what is actually established, read the FDA label.
Source: openFDA drug/event (FAERS), retrieved September 26, 2026.
Reviews
No reviews yet. Be the first to write one.
People also viewed
colazal
Balsalazide Disodium
adrenaclick
Epinephrine
amjevita
Adalimumab-Atto
atrovent hfa
Ipratropium Bromide
canasa
Mesalamine
cortenema
Hydrocortisone
Compare Kenacort head-to-head
Browse medications A–Z
Research products from A to Z, compare independent ratings, and find alternatives.
kenacort
New